Varda Space Industries has raised $187 million in a funding round, with the transaction primarily focusing on scaling its technology for robotic drug manufacturing in microgravity. The capital will enhance the company's ability to produce pharmaceutical formulations that cannot be created on Earth and support the expansion of its operations with new facilities in Huntsville and El Segundo.

Summary of transaction details:

• Deal Type: Funding Round
• Transaction Amount: $187,000,000
• Company Name: Varda Space Industries
• Founders: Delian Asparouhov
• Current CEO: Will Bruey
• Headquarters: Los Angeles, California
• Notable Investors: Natural Capital, Shrug Capital, Lux Capital, Peter Thiel, Founders Fund, Khosla Ventures

Varda Space Industries is co-founded by Delian Asparouhov, and under the leadership of CEO Will Bruey, the company focuses on innovative approaches to pharmaceutical manufacturing. The recent funding brings Varda's total to $329 million, positioning it for significant growth in the biotech sector, particularly in areas requiring advanced manufacturing techniques in unique environments. The involvement of notable investors highlights the industry's interest in Varda's capabilities and potential market impact.